Pura Vida Investments
New York, New York, United StatesFounded 2012
Pura Vida Investments is a New York-based, healthcare-focused investment firm employing a fundamentally-driven, market-neutral approach. It invests across medical technology, diagnostics, genomics, biopharmaceuticals, and health-tech, spanning both public and private markets.
36% of their portfolio is in Healthcare. Average disclosed round size is $166.3M (across 20 rounds with reported amounts).
Portfolio
19
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
AG
Aditya Gupta
Principal
GO
Gerrel Olivier
Senior Analyst
TH
Tae-Il Ha
Senior Analyst
BB
Beau Bassett
Investment Manager
YX
Yifan Xu
Healthcare Investor
MN
Matthew Newton
Head of Equities
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
22 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| NNalu | Series E | $65M | Mar 2024 |
| FFreenome | Growth | $254M | Feb 2024 |
 Beta Bionics | Series C | $57M | Feb 2022 |
| BBeta Bionics, Inc. | Series C | $57M | Feb 2022 |
 Freenome Inc | Series D | $300M | Dec 2021 |
 NanoMosaic | Series A | $40.8M | Dec 2021 |
 Exo Labs | Series C | $220M | Jul 2021 |
 Caris Life Sciences | Growth | $830M | May 2021 |
 Lumicks | Series D | $93M | Apr 2021 |
| LLumicks B.V. | Series D | $93M | Apr 2021 |
| Lumicks | Series D | $93M | Jan 2021 |
 V-Wave | Series C | $98M | Sep 2020 |
 MedAvail | Bridge | $84M | Jan 2018 |
| VV-Wave Ltd. | Series B | $28M | Jan 2016 |
 AtaiBeckley | Series C | — | — |
| AtaiBeckley | Growth | $43M | — |
 Exo | Series C | — | — |
 Monogram Health | Unknown | $375M | — |
 Nalu Medical | Series E | $85M | — |
 Imperative Care | Series D | $260M | — |
 Exo Imaging | Series C | $220M | — |
| MedAvail | Series C | $30M | — |
Top Co-Investors
RA Capital Management6 shared
T. Rowe Price6 shared
Farallon Capital Management5 shared
Perceptive Advisors5 shared
Sands Capital5 shared
Gilde Healthcare5 shared
Eventide Asset Management4 shared
ArrowMark Partners4 shared
Endeavour Vision4 shared
Catalio Capital Management3 shared
Soleus Capital3 shared
Bain Capital Life Sciences3 shared
Rock Springs Capital3 shared
Aperture Venture Partners3 shared
Deerfield3 shared
Avidity Partners3 shared
Ally Bridge Group3 shared
Lauxera Capital Partners3 shared
Apeiron Investment Group2 shared
RTW Investments, LP2 shared
Last updated: 8 September 2026